Indications

Prescribing Information

Next Page Icon

Medication Guide

Next Page Icon
Potential OPDIVO® (nivolumab) user fishing with his young grandson.
Potential OPDIVO® (nivolumab) user fishing with his young grandson.

Clinical trial results for
advanced colorectal cancer
(MSI-H/dMMR)

See results for OPDIVO immunotherapy, alone or in combination with YERVOY

Actor portrayals.
OPDIVO or OPDIVO + YERVOY is not approved
for people younger than 12 years of age.

Previously treated colorectal cancer (MSI-H/dMMR)

OPDIVO + YERVOY

For certain adults and children 12 years and older who have had prior treatments for MSI-H/dMMR colorectal cancer

Previously treated colorectal cancer (MSI-H/dMMR)

OPDIVO

For certain adults and children 12 years and older who have had prior treatments for MSI-H/dMMR colorectal cancer

OPDIVO will not work for everyone. Individual results may vary.

Hands exploring how OPDIVO® (nivolumab) works and learning how this treatment may help fight cancer.

How treatment works

See how this treatment may help your body fight cancer

OPDIVO® (nivolumab) side effects.

Side effects

View side effects of treatment and learn how to manage them

Nurse monitoring a gentleman's infusion of OPDIVO® (nivolumab) immunotherapy treatment.

Getting an infusion

See your recommended treatment plan and what to expect from an infusion



466-US-2400031   03/24